Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS - Sarepta Therapeutics

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Jul. 25, 2025-- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Ju…